@article{f3d662cf6c1e4d5aa471492e22427d39,
title = "What is important for people with nontuberculous mycobacterial disease? An embarc-elf patient survey: An EMBARC-ELF patient survey",
abstract = "Patients' experiences of NTM pulmonary disease highlight important and unmet needs for better pharmacological treatment and education of medical staff https://bit.ly/3mjrlwh.",
author = "Michal Shteinberg and Jeanette Boyd and Stefano Aliberti and Eva Polverino and Bridget Harris and Tove Berg and Annette Posthumus and Thomas Ruddy and Pieter Goeminne and Ernie Lloyd and Timothy Alan and Josje Altenburg and Barbara Crossley and Francesco Blasi and James Chalmers",
note = "Funding Information: Support statement: This study was supported by the European Respiratory Society EMBARC Clinical Research Collaboration. Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: M. Shteinberg reports grants, personal fees and nonfinancial support from GSK, grants and personal fees from Novartis, personal fees from Boehringer Ingelheim, AstraZeneca, Kamada, Vertex Pharmaceuticals and Teva, nonfinancial support from Actelion, grants, personal fees and nonfinancial support from GSK, grants from Novartis, nonfinancial support from Rafa, and grants from Trudell Pharma, outside the submitted work. Jeanette Boyd is an employee of the European Lung Foundation. S. Aliberti reports advisory fees and research support from Bayer Healthcare; speaker fees from Grifols; advisory fees from Astra Zeneca; advisory and speaker fees from Zambon; advisory and speaker fees, and research support from Chiesi and Insmed; advisory and speaker fees from GlaxoSmithKline; speaker fees from Menarini; advisory fees from ZetaCube Srl; and research support from Fisher \& Paykel, all outside the submitted work. E. Polverino has nothing to disclose. B. Harris has nothing to disclose. T. Berg has nothing to disclose. A. Posthumus has nothing to disclose. T. Ruddy has nothing to disclose. P. Goeminne has nothing to disclose. E. Lloyd has nothing to disclose. T. Alan has nothing to disclose. J. Altenburg has nothing to disclose. B. Crossley has nothing to disclose. F. Blasi reports a research grant and an advisory fee from AstraZeneca; a research grant from Bayer; research grants and advisory fees from Chiesi and GSK; advisory fees from Grifols, Guidotti Funding Information: and Insmed; a research grant and an advisory fee from Menarini; an advisory fee from Novartis; a research grant and an advisory fee from Pfizer; and advisory fees from Zambon and Vertex, all outside the submitted work. J. Chalmers reports grants and personal fees from AstraZeneca and Boehringer Ingelheim, personal fees from Chiesi, grants and personal fees from GlaxoSmithKline, grants from Gilead Sciences, grants and personal fees from Insmed, and personal fees from Novartis and Zambon, outside the submitted work.",
year = "2021",
month = jan,
doi = "10.1183/23120541.00807-2020",
language = "English",
volume = "7",
journal = "ERJ open research",
issn = "2312-0541",
publisher = "European Respiratory Society",
number = "1",
}